August 20, 2018
The Pennsylvania Commonwealth Court recently issued a decision in the matter of Armour Pharmacy v. Bureau of Workers’ Compensation Fee Review Hearing Office (National Fire Insurance Company of Hartford), in which it held that a compromise and release (C&R) agreement could not be used to avoid payments already owed to a provider by an employer. Specifically, the Court refused to set aside a fee review determination that an employer owed reimbursement to a pharmacy for prescription compound creams and, instead, determined that the pharmacy was not bound by the C&R agreement entered into by the claimant and the employer, where the parties had stated that neither the claimant nor the employer would be responsible for past charges related to those prescription compound creams. A copy of the Opinion is available here.
In Armour Pharmacy, the employer and claimant originally entered into a C&R agreement with regard to indemnity benefits only. Since 2000, the employer covered the claimant’s medical treatment. In 2015, the employer requested a utilization review of a topical compound cream prescribed by the claimant’s physician; the cream was found to be reasonable and necessary. The employer did not appeal that decision.
In early 2016, after the employer refused to pay the pharmacy’s invoices for the cream, on the basis of a “utilization review,” the provider filed a timely fee review application. The Commonwealth Court noted that the employer’s stated response was false in light of the prior unfavorable utilization review and the fact that the employer had not sought a new utilization review relative to the 2016 prescriptions/treatment. The Medical Fee Review Section determined that the employer owed the pharmacy $6,644.30 plus interest. Before a hearing officer, the employer presented a copy of a 2016 C&R agreement, which was approved by a workers’ compensation judge three months after the Medical Fee Review Section directed the employer to pay the pharmacy. The agreement specifically stated that “no past, present or future benefits shall be paid for any compounded prescription cream.” The agreement also stated that neither the provider nor the pharmacy shall hold the claimant liable for the cream, since the employer has reason to believe that the physician has a financial interest in the pharmacy in violation of Section 306(f.1)(3) of the Act. The hearing officer held that, in light of the 2016 C&R agreement, the employer was not responsible for the payment to the pharmacy.
The Commonwealth Court noted that the 2016 C&R agreement obligated the employer to pay for reasonable, necessary and related medical expenses incurred prior to the hearing date for the agreement, which would include the compound creams that had already been dispensed by the pharmacy as of that date. Finally, the Court held that, while a valid C&R agreement is “binding upon the parties,” the agreement at issue did not bind the pharmacy since it was not a party to the agreement. The Court explained the use of the C&R agreement to deprive the provider of the review procedures and excuse the employer from paying the provider under these circumstances violates the Act and the provider’s due process rights.
Under Armour Pharmacy, employers and claimants are unable to avoid payment of outstanding medical expenses, including expensive compound creams, by way of C&R agreements, where an employer is already paying medical benefits for an accepted injury and where a fee review determination has already been made in favor of the pharmacy.
In light of Armour Pharmacy, it is important that parties attempt to determine the amount of outstanding medical expenses when settling an already-accepted workers’ compensation claim. When faced with settlement, many providers are willing to negotiate directly for a compromised payment instead of opting for the fee review process and potential protracted litigation. Importantly, however, Armour Pharmacy does not impact the parties’ ability to compromise and release a disputed denied claim and to agree to pay no medical expenses or only designated medical expenses as part of the C&R agreement.
If you have questions about this case, or a specific claim, please contact the following Post & Schell’s Workers’ Compensation Attorneys:
- Workers’ Compensation Department Chair, Jonathan C. Ascher, Esquire at (412) 577-2982 or email@example.com;
- Patrick R. Byrne, Esquire in our Allentown Office at (610) 774-0326 or firstname.lastname@example.org;
- Patrick T. Cusick, Esquire in our Lancaster Office at (717) 391-4418 or email@example.com; or
- Patrice A. Toland, Esquire in our Philadelphia Office at (215) 587-1093 or firstname.lastname@example.org.
Disclaimer: This post does not offer specific legal advice, nor does it create an attorney-client relationship. You should not reach any legal conclusions based on the information contained in this post without first seeking the advice of counsel.
About the Author:
Karyn D. Rienzi is a Principal in the Firm's Appellate Department and focuses her practice exclusively on post-trial and appellate matters in a variety of practice areas, including casualty, insurance coverage, premises liability, products liability, and workers’ compensation. In her appellate practice, Ms. Rienzi works closely with trial attorneys on pre-trial and trial strategies in state and federal court to protect and enhance a client’s post-trial and appellate rights. Learn More.